Back to Journals » International Journal of Women's Health » Personalized and Translational Innovation in Gynecologic Cancer Care
International Journal of Women's Health
- View all (2608)
- Volume 18, 2026 (451)
- Volume 17, 2025 (493)
- Volume 16, 2024 (216)
- Volume 15, 2023 (192)
- Volume 14, 2022 (164)
- Volume 13, 2021 (121)
- Volume 12, 2020 (134)
- Volume 11, 2019 (70)
- Volume 10, 2018 (87)
- Volume 9, 2017 (101)
- Volume 8, 2016 (75)
- Volume 7, 2015 (102)
- Volume 6, 2014 (111)
- Volume 5, 2013 (96)
- Volume 4, 2012 (73)
- Volume 3, 2011 (53)
- Volume 2, 2010 (48)
- Volume 1, 2009 (21)
Journal Articles:
- Cervical Cancer Screening: From Detection to Management (2)
- Understanding Pelvic Floor Dysfunctions: Causes, Treatments, and Advances in Care (4)
- Women’s Health Month 2024 (5)
- The Prevention, Early Diagnosis and Treatment of Cervical Cancer (7)
- The Vulvodynia Frontier: Where do we go from here? (4)
- Strengths-based approaches to optimizing perinatal mental health and wellbeing (1)
- Pain Relief and Care for Endometriosis (3)
- Prediction and prevention of preterm birth (1)
- Abortion: accessibility and safety (2)
- Window to the womb: amniotic fluid volume and postnatal outcomes (1)
Personalized and Translational Innovation in Gynecologic Cancer Care
Gynecologic cancers, including ovarian, endometrial, cervical, vulvar and vaginal cancers, remain major threats to women's health across the life course. Their prevention, diagnosis and treatment are being reshaped by advances in molecular classification, high throughput sequencing, spatial and single cell technologies, immunology, minimally invasive surgery, targeted therapy and patient centered care. At the same time, the biological and clinical diversity of these diseases continues to challenge conventional approaches to screening, risk stratification and treatment selection. This Article Collection will bring together research focused on precision medicine and translational innovation in gynecologic oncology, with an emphasis on how laboratory discoveries, clinical evidence and real world practice can be integrated to improve outcomes for women with gynecologic malignancies.
